Provepharm Sas Drug Patent Portfolio
Provepharm Sas owns 1 orange book drug protected by 3 US patents Given below is the list of Provepharm Sas's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10927258 | Process for the preparation of Indigotindisulfonate sodium (indigo carmine) | 23 Dec, 2037 | Active |
| US11499050 | Process for the preparation of indigotindisulfonate sodium (indigo carmine) | 23 Dec, 2037 | Active |
| US11845867 | Process for the preparation of indigotindisulfonate sodium (indigo carmine) | 25 Nov, 2036 | Active |
Latest Legal Activities on Provepharm Sas's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Provepharm Sas.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 20 Dec, 2023 | US11845867 |
|
Recordation of Patent Grant Mailed
Critical
| 19 Dec, 2023 | US11845867 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 19 Dec, 2023 | US11845867 |
| Patent eGrant Notification | 19 Dec, 2023 | US11845867 |
| Recordation of Patent eGrant | 19 Dec, 2023 | US11845867 |
| Mail Patent eGrant Notification | 19 Dec, 2023 | US11845867 |
|
Email Notification
Critical
| 30 Nov, 2023 | US11845867 |
|
Issue Notification Mailed
Critical
| 29 Nov, 2023 | US11845867 |
| Dispatch to FDC | 07 Nov, 2023 | US11845867 |
|
Application Is Considered Ready for Issue
Critical
| 07 Nov, 2023 | US11845867 |
|
Issue Fee Payment Received
Critical
| 03 Nov, 2023 | US11845867 |
|
Issue Fee Payment Verified
Critical
| 03 Nov, 2023 | US11845867 |
| Workflow - Drawings Finished | 31 Aug, 2023 | US11845867 |
| Mail PUB other miscellaneous communication to applicant | 22 Aug, 2023 | US11845867 |
|
Email Notification
Critical
| 22 Aug, 2023 | US11845867 |
Provepharm Sas's Family Patents
Provepharm Sas Drug List
Given below is the complete list of Provepharm Sas's drugs and the patents protecting them.
1. Bludigo
Bludigo is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10927258 | Process for the preparation of Indigotindisulfonate sodium (indigo carmine) |
23 Dec, 2037
(13 years from now)
| Active |
| US11499050 | Process for the preparation of indigotindisulfonate sodium (indigo carmine) |
23 Dec, 2037
(13 years from now)
| Active |
| US11845867 | Process for the preparation of indigotindisulfonate sodium (indigo carmine) |
25 Nov, 2036
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Bludigo's drug page